MetLife Investment Management’s Anika Therapeutics ANIK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-8,516	Closed	-$128K	–	2789
2025 Q1	$128K	Hold	8,516	–	–	﹤0.01%	2412
2024 Q4	$140K	Hold	8,516	–	–	﹤0.01%	2473
2024 Q3	$210K	Hold	8,516	–	–	﹤0.01%	2263
2024 Q2	$216K	Buy	8,516 +831	+11%	+$21K	﹤0.01%	2195
2024 Q1	$195K	Hold	7,685	–	–	﹤0.01%	2222
2023 Q4	$174K	Hold	7,685	–	–	﹤0.01%	2314
2023 Q3	$143K	Hold	7,685	–	–	﹤0.01%	2391
2023 Q2	$200K	Hold	7,685	–	–	﹤0.01%	2279
2023 Q1	$221K	Hold	7,685	–	–	﹤0.01%	2153
2022 Q4	$227K	Sell	7,685 -845	-10%	-$25K	﹤0.01%	2170
2022 Q3	$203K	Hold	8,530	–	–	﹤0.01%	2291
2022 Q2	$190K	Hold	8,530	–	–	﹤0.01%	2354
2022 Q1	$214K	Buy	8,530 +3,582	+72%	+$89.9K	﹤0.01%	2319
2021 Q4	$177K	Sell	4,948 -2,139	-30%	-$76.6K	﹤0.01%	2125
2021 Q3	$302K	Hold	7,087	–	–	﹤0.01%	1819
2021 Q2	$307K	Hold	7,087	–	–	﹤0.01%	1871
2021 Q1	$289K	Hold	7,087	–	–	﹤0.01%	1832
2020 Q4	$321K	Hold	7,087	–	–	﹤0.01%	1725
2020 Q3	$251K	Hold	7,087	–	–	﹤0.01%	1722
2020 Q2	$267K	Hold	7,087	–	–	﹤0.01%	1727
2020 Q1	$205K	Hold	7,087	–	–	﹤0.01%	1683
2019 Q4	$367K	Hold	7,087	–	–	﹤0.01%	1626
2019 Q3	$389K	Hold	7,087	–	–	﹤0.01%	1558
2019 Q2	$288K	Hold	7,087	–	–	﹤0.01%	1813
2019 Q1	$214K	Hold	7,087	–	–	﹤0.01%	1946
2018 Q4	$238K	Hold	7,087	–	–	﹤0.01%	1809
2018 Q3	$299K	Hold	7,087	–	–	﹤0.01%	1859
2018 Q2	$227K	Hold	7,087	–	–	﹤0.01%	1870
2018 Q1	$352K	Hold	7,087	–	–	﹤0.01%	1591
2017 Q4	$382K	Buy	+7,087	New	+$382K	﹤0.01%	1564